Digital health funding reached $986M across 61 digital health deals in Q1 2019, according to Rock Health, a full-service venture fund dedicated to digital health. The Q1 2019 funding represents about half of the $1.62B that was raised a year ago in Q1 2018 but in line with 2017 and 31% below 2016. Compared to the $1.2B in Q4 2018, quarterly funding has averaged $1.4B over the past two years (Q1 2017-Q1 2019). Rock Health signals the $986M invested in this past quarter are somewhat below
Read More
M&A
2018 Healthcare M&A in Review: 4 Trends Reshaping the Healthcare Landscape
The trend of mergers between large healthcare provider organizations continued in 2018, as the average size in revenue of sellers (defined as the smaller of two organizations in a transaction) reached $409 million, according to Kaufman Hall's new report, 2018 M&A in Review: A New Healthcare Landscape Takes Shape. This is the highest figure seen since Kaufman Hall began tracking this metric in 2008. It also represents a compound annual growth rate (CAGR) of almost 14 percent in the average
Read More
OurCrowd Launches Israel’s First $50M Digital Health Fund
OurCrowd, an Jerusalem-based global equity crowdfunding platform for accredited investors has launched Israel's first $50 million fund to invest in digital health startups. The new fund called OurCrowd Qure will focus on digital health startups at seed and series A stages in Israel, the US and the Asia Pacific region. Allen Kamer and Dr. Yossi Bahagon has been appointed to lead the fund.OurCrowd Qure has established a collaboration with Johns Hopkins University to provide validation of value,
Read More
M&A Expert Talks 4 Trends Emerging from the Health IT M&A Market
As Managing Director of SC&H Capital, an investment banking and advisory firm, Chris Helmrath knows M&A opportunities when he sees them. And in today’s HIT M&A market, he sees a rapid shift from mega mergers to middle-market acquisitions.In our interview, Chris—a 30-year veteran of buy- and sell-side healthcare transactions—discusses four key trends emerging from the evolving health IT M&A market, as well as what they mean for consultants and their clients. Trend No. 1. A More
Read More
Report: Life Sciences M&A and the Rise of Personalized Medicine
As the life sciences (pharmaceuticals, biotechnology and medical sectors) M&A reaches new heights, there seems to be no end in sight for life sciences companies' hunger for acquisitions. 94% of life sciences companies are planning to make an acquisition in the next year, with 91% of US respondents expecting these to be cross-border transactions, according to a global study of 100 senior executives at life sciences companies by global law firm Reed Smith, commissioned by Mergermarket. The
Read More
